Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

RSS Feed

Home
/
Brands
/
SCA Pharmaceuticals

SCA Pharmaceuticals Recalls

All product recalls associated with SCA Pharmaceuticals.

Get alerts for this brand

Recall Summary

Total Recalls

1000

Past Year

303

Class I (Serious)

Most Recent

Nov 2025

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 1341–1360 of 4747 recalls

Lidocaine HCl 1% Injection (SCA Pharmaceuticals) – Sterility Concern (2020)

Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit

Class IIModerate

FDADec 17, 2020Nationwide• SCA Pharmaceuticals

Rocuronium Bromide Injection (SCA Pharmaceuticals) – Sterility Concern (2020)

Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit

Class IIModerate

FDADec 17, 2020Nationwide• SCA Pharmaceuticals

Neostigmine Methylsulfate Injection (SCA Pharmaceuticals) – Sterility Concern (2020)

Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit

1...66 676869 70...238

Page 68 of 238Next

Class II

Moderate

FDADec 17, 2020Nationwide• SCA Pharmaceuticals

Lidocaine HCl 2% Injection (SCA Pharmaceuticals) – Sterility Concern (2020)

Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit

Class IIModerate

FDADec 17, 2020Nationwide• SCA Pharmaceuticals

Ketamine Sodium Chloride Injection (SCA Pharmaceuticals) – Sterility Concern (2020)

Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit

Class IIModerate

FDADec 17, 2020Nationwide• SCA Pharmaceuticals

Phenylephrine HCl Injection (SCA Pharmaceuticals) – sterility concern (2020)

Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit

Class IIModerate

FDADec 17, 2020Nationwide• SCA Pharmaceuticals

Phenylephrine HCl Injection (SCA Pharmaceuticals) – sterility concern (2020)

Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit

Class IIModerate

FDADec 17, 2020Nationwide• SCA Pharmaceuticals

Hydromorphone HCl Injection (SCA Pharmaceuticals) – sterility concern (2020)

Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit

Class IIModerate

FDADec 17, 2020Nationwide• SCA Pharmaceuticals

Lidocaine HCl Injection (SCA Pharmaceuticals) – sterility concern (2020)

Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit

Class IIModerate

FDADec 17, 2020Nationwide• SCA Pharmaceuticals

Rocuronium Bromide (SCA Pharmaceuticals) – sterility concern (2020)

Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit

Class IIModerate

FDADec 17, 2020Nationwide• SCA Pharmaceuticals

Phenylephrine HCl Injection (SCA Pharmaceuticals) – sterility concern (2020)

Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit

Class IIModerate

FDADec 17, 2020Nationwide• SCA Pharmaceuticals

Ketamine Injection (SCA Pharmaceuticals) – sterility concern (2020)

Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit

Class IIModerate

FDADec 17, 2020Nationwide• SCA Pharmaceuticals

Hydromorphone Sodium Chloride Injection (SCA Pharmaceuticals) – Sterility Concern (2020)

Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit

Class IIModerate

FDADec 17, 2020Nationwide• SCA Pharmaceuticals

Succinylcholine Chloride Injection (SCA Pharmaceuticals) – Sterility Concern (2020)

Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit

Class IIModerate

FDADec 17, 2020Nationwide• SCA Pharmaceuticals

Morphine Sulfate Injection (SCA Pharmaceuticals) – sterility concern (2020)

Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit

Class IIILow

FDADec 17, 2020Nationwide• SCA Pharmaceuticals

Succinylcholine Chloride (SCA Pharmaceuticals) – sterility concern (2020)

Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit

Class IIModerate

FDADec 17, 2020Nationwide• SCA Pharmaceuticals

Fentanyl High Dose Injection (SCA Pharmaceuticals) – Sterility Concern (2020)

Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit

Class IIModerate

FDADec 17, 2020Nationwide• SCA Pharmaceuticals

Phenylephrine HCl Injection (SCA) – Sterility Risk (2020)

Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit

Class IIModerate

FDADec 17, 2020Nationwide• SCA Pharmaceuticals

Ephedrine Sulfate Sodium Chloride Injection (SCA Pharmaceuticals) – Sterility Concern (2020)

Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit

Class IIModerate

FDADec 17, 2020Nationwide• SCA Pharmaceuticals

Morphine Sulfate Sodium Chloride Injection (SCA Pharmaceuticals) – Sterility Concern (2020)

Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit

Class IIModerate

FDADec 17, 2020Nationwide• SCA Pharmaceuticals